Literature DB >> 16686527

Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists.

Anandan Palani1, Jayaram R Tagat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16686527     DOI： 10.1021/jm060009x

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  13 in total

1.  Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity.

Authors:  Luca Vangelista; Renato Longhi; Francesca Sironi; Vincenzo Pavone; Paolo Lusso
Journal:  Biochem Biophys Res Commun       Date:  2006-10-26       Impact factor: 3.575

2.  Binding modes of CCR5-targetting HIV entry inhibitors: partial and full antagonists.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Graph Model       Date:  2007-12-17       Impact factor: 2.518

Review 3.  Maraviroc.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5.

Authors:  Ya Zhu; Yan-Long Zhao; Jian Li; Hong Liu; Qiang Zhao; Bei-Li Wu; Zhen-Lin Yang
Journal:  Acta Pharmacol Sin       Date:  2018-06-25       Impact factor: 6.150

5.  Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity.

Authors:  Chu-Biao Xue; Lihua Chen; Ganfeng Cao; Ke Zhang; Anlai Wang; David Meloni; Joseph Glenn; Rajan Anand; Michael Xia; Ling Kong; Taisheng Huang; Hao Feng; Changsheng Zheng; Mei Li; Laurine Galya; Jiacheng Zhou; Niu Shin; Fredric Baribaud; Kim Solomon; Peggy Scherle; Bitao Zhao; Sharon Diamond; Tom Emm; Douglas Keller; Nancy Contel; Swamy Yeleswaram; Kris Vaddi; Gregory Hollis; Robert Newton; Steven Friedman; Brian Metcalf
Journal:  ACS Med Chem Lett       Date:  2010-08-25       Impact factor: 4.345

Review 6.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

Review 7.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 8.  Maraviroc: a review of its use in the management of CCR5-tropic HIV-1 infection.

Authors:  Caroline M Perry
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

9.  Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.

Authors:  Qiuxiang Tan; Ya Zhu; Jian Li; Zhuxi Chen; Gye Won Han; Irina Kufareva; Tingting Li; Limin Ma; Gustavo Fenalti; Jing Li; Wenru Zhang; Xin Xie; Huaiyu Yang; Hualiang Jiang; Vadim Cherezov; Hong Liu; Raymond C Stevens; Qiang Zhao; Beili Wu
Journal:  Science       Date:  2013-09-12       Impact factor: 47.728

10.  Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening.

Authors:  Mariam A El-Zohairy; Darius P Zlotos; Martin R Berger; Hassan H Adwan; Yasmine M Mandour
Journal:  ACS Omega       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.